Atlanta, GA – According to filings with the U.S. Securities and Exchange Commission, Micron Biomedical is raising $14,000,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Idean Marvasty played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Micron Biomedical

Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to improve safety and efficacy by skin targeting.

To learn more about Micron Biomedical, visit http://micronbiomedical.com/

Contact:
Idean Marvasty, Chief Financial Officer
404-368-1554

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved